SCHOLARLY PUBLICATION
✓ Open Access
KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer
📄 Abstract
mutation frequency, pancreatic ductal adenocarcinoma (PDAC) is considered the most RAS-addicted of all cancers. We review the role of KRAS as a driver and therapeutic target in PDAC.
📤 Share this page
Found this useful? Share it with your network.